-
Drug companies should meet payers' expectations of value, report finds
NEW YORK — More than 80% of health plans would require a drug manufacturer to demonstrate a clear clinical benefit compared with current branded and generic treatments in order for its drug to be placed in the plan's formulary, according to a new survey.
-
Sagent launches generic chemotherapy drug
SCHAUMBURG, Ill. — Sagent Pharmaceuticals has launched a generic version of a chemotherapy drug, the company said Thursday.
Sagent announced the launch of irinotecan injection, a generic version of Pfizer's Camptosar, in latex-free, preservative-free, single-dose vials.
Various versions of the drug had sales of about $28 million during the 12-month period ended in March, according to IMS Health.